Vivo Bio Tech Ltd
Vivo Bio Tech Ltd Live Price Chart
Performance
| Previous Close | ₹ 13.87 |
| High | ₹ 14.09 |
| Volume | 15018 |
| 52W Range | ₹ 12 - ₹ 20.94 |
| Open | ₹ 13.58 |
| Low | ₹ 13.51 |
| Market Cap | ₹ 33.06 Cr |
Vivo Bio Tech Ltd Technicals
| 20 Day | ₹ 14.469 |
| 50 Day | ₹ 16.522 |
| 100 Day | ₹ 19.182 |
| 200 Day | ₹ 22.937 |
| 20 Day | ₹ 14.498 |
| 50 Day | ₹ 16.602 |
| 100 Day | ₹ 19.781 |
| 200 Day | ₹ 23.508 |
Vivo Bio Tech Ltd Fundamentals
| ROCE | 6.639 |
| P/E Ratio | -9.820 |
| P/B Ratio | 0.340 |
| Industry P/E | 0.340 |
| Debt to Equity | 49.874 |
| ROE | -2.077 |
| EPS | -1.410 |
| Dividend Yield | 0.000 |
| Book Value | 41.278 |
| Face Value | 10.000 |
Vivo Bio Tech Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 53.0093 | 51.4774 | 44.9193 | 51.6579 | 51.4831 |
| Total Expenses | 47.8222 | 42.3963 | 40.8645 | 47.0525 | 47.0092 |
| Profit After Tax | -1.9361 | 7.5707 | 2.5223 | 2.634 | 2.2033 |
Vivo Bio Tech Ltd Shareholding Pattern
| Promoter Holdings | 22.507 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 32.604 % |
| Others - | 44.889 % |
About Vivo Bio Tech Ltd
Vivo Bio Tech Limited, established on 12 February 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies, Genotoxicity screening, Analytical services etc. The Company has pioneered as a primary provider of SPF lab animals in India. It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences. The Company serves as an authorized distributor of lab animal diets from Special Diets Services (UK) in India. Their comprehensive services span a wide array of preclinical toxicology disciplines, encompassing In-vitro and In-vivo studies, analytical chemistry studies, bioanalytical studies, and physico-chemical studies. Vivo Bio has partnered with Taconic Biosciences for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents. The Company partnered Cyagen Biosciences to access genomic technologies in 2016. It commenced breeding and distribution of SPF guinea pigs in 2017. The Company acquired 100% shareholding in M/s. Donakanti Consulting Services Private Ltd on 17 April, 2019. It received ISO 9001:2015 Certific ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 35.25 -0.28 (-0.79%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 498.00 +5 (+1.01%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,306.00 +69 (+1.11%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 673.00 +24.5 (+3.78%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,245.00 -30 (-0.11%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,354.90 -10.7 (-0.78%) |
FAQs on Vivo Bio Tech Ltd
1. Can I buy Vivo Bio Tech Ltd from PL Capital? ›
2. Does Vivo Bio Tech Ltd pay dividends? ›
3. What is the current share price of Vivo Bio Tech Ltd ? ›
4. What is the 52-week high and low of Vivo Bio Tech Ltd ? ›
5. What is the market capitalisation of Vivo Bio Tech Ltd? ›
6. What is the current P/E ratio of Vivo Bio Tech Ltd? ›
7. What is the current P/B ratio of Vivo Bio Tech Ltd? ›
8. What is the shareholding pattern of Vivo Bio Tech Ltd? ›
9. What is the 1-year return of Vivo Bio Tech Ltd? ›
Start SIP in Vivo Bio Tech Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
